United States · FDA National Drug Code directory
Linagliptin and metformin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-408_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb
- Product NDC
- 72205-408
- Form
- TABLET, FILM COATED
- Composition / generic term
- Linagliptin and metformin hydrochloride
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251103
- Source listing expiry
- 20261231
Source-listed ingredients
- LINAGLIPTIN — 2.5 mg/1
- METFORMIN HYDROCHLORIDE — 850 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (72205-408-01) · 72205-408-01
- 180 TABLET, FILM COATED in 1 BOTTLE (72205-408-02) · 72205-408-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →